Primary Combined Hepatocellular-Cholangiocarcinoma: A Case of Underdiagnosed Primary Liver Cancer.
| Autor: | Ayas MF; Internal Medicine, Ascension St. John Hospital, Detroit, USA., Affas S; Internal Medicine, Ascension St. John Hospital, Detroit, USA., Ayas Z; Basic Sciences, College of Natural Sciences, University of Texas at Austin, Austin, USA., Chand M; Pathology, Ascension St. John Hospital, Detroit, USA., Hadid T; Oncology, Ascension St. John Hospital, Detroit, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2021 Sep 23; Vol. 13 (9), pp. e18224. Date of Electronic Publication: 2021 Sep 23 (Print Publication: 2021). |
| DOI: | 10.7759/cureus.18224 |
| Abstrakt: | Combined hepatocellular-cholangiocarcinoma (CHC) is a rare primary tumor of the liver. Histologically, it comprises components of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) but is associated with a worse prognosis. International guidelines regarding its management are scarce, with surgical management (major hepatectomy) being the treatment of choice. In this report, we present a challenging case of a 73-year-old male with primary CHC who was not a surgical candidate but underwent hepatic artery radioembolization instead. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Ayas et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|